Treatment of acute contrast reactions

Radiology Life Support (RAD-LS): A Practical Approach

Volumn , Issue , 2017, Pages 31-51

  Bush, William H ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002605967     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203741320     Document Type: Chapter

References (76)

1. Swanson DP Shetty PC, Kastan DJ, Rollins N. Angiographic contrast media. In: Swanson D, Chilton H, Thrall J, eds. Pharmaceuticals in medical imaging. New York: Macmillan, 1990, 13-39.
2. Thrall JH. Adverse reactions to contrast media: etiology, incidence, treatment, prevention. In: Swanson DP Chilton HM, Thrall JH eds., Pharmaceuticals in medical imaging. New York: Macmillan, 1990: 253-77.
3. Bush WH, Swanson DR Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. American Journal of Roentgenology 1991; 157: 1153-61.
4. Lieberman P Anaphylactoid reactions to radiocontrast material. Immunology and Allergy Clinics 1992; 12: 649-70.
5. Almen T. The etiology of contrast medium reactions. Investigative Radiology 1994; 29 (Supplement 1), S37-S45.
6. Bush WH. Risk factors, prophylaxis and therapy of X-ray contrast media reactions. Advances in X-ray Contrast 1996; 3: 44-53.
7. Spinazzi A, Davies A, Rosati G. Predictable and unpredictable adverse reactions to uroangiographic contrast media. Academic Radiology 1996; 3: 5210-13.
8. Davies P Roberts MB, Roylance J. Acute reactions to urographic contrast media. British Medical Journal 1975; 2: 434-7.
9. McCullough M, Davies P Richardson R. A large trial of intravenous Conray 325 and Niopam 300 to assess immediate and delayed reactions. British Journal of Radiology 1989; 62: 260-65.
10. Wolf GL, Arenson RL, Cross AP. A prospective trial of ionic vs. nonionic contrast agents in routine clinical practice: comparison of adverse effects. American journal of Roentgenology 1989; 152: 939-44.
11. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P Matsuura K. Adverse reactions to ionic and nonionic contrast media: a report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990; 175: 621-8.
12. Caro JJ, Trindade E, McGregor M. The risks of death and of severe nonfatal reactions with high-vs. low-osmolality contrast media: a meta-analysis. American Journal of Roentgenology 1991; 156: 825-32.
13. Lawrence V, Matthai W, Hartmaier S. Comparative safety of high-osmolality and low-osmolality radiographic contrast agents. Report of a multidisciplinary working group. Investigative Radiology 1992; 27: 2-28.
14. Yoshikawa H. Late adverse reactions to non-ionic contrast media. Radiology 1992; 183:737-40.
15. Shehadi WH. Death following intravascular administration of contrast media. Acta Radiologica: Diagnosis 1985; 26: 457-61.
16. Hartman GW, Hattery RR, Witten DM, Williamson B. Mortality during excretory urography: Mayo Clinic experience. American Journal of Roentgenology 1982; 139: 919-22.
17. Siegle RL. Rates of idiosyncratic reactions. Ionic versus nonionic contrast media. Investigative Radiology 1993; 28 (Supplement 5): S95-S98.
18. Bush WH, McClennan BL, Swanson DP Contrast media reactions: prediction, prevention and treatment. Postgraduate Radiology 1993; 13: 137-47.
19. McClennan BL. Adverse reactions to iodinated contrast media. Recognition and response. Investigative Radiology 1994; 29 (Supplement 1) : S46-S50.
20. Curry N, Schabel S, Reiheld C et al. Fatal reactions to intravenous nonionic contrast material. Radiology 1991; 178 : 361-2.
21. Baltaoglu G, Balkanci R, Tirnaksiz B. Fatal reaction after intra-arterial injection of nonionic contrast medium (letter). American Journal of Roentgenology 1994; 162: 231.
22. Shellock R, Hahn H, Mink J et al. Adverse reaction to intravenous gadoteri-dol. Radiology 1993; 189: 151-2.
23. Murphy K, Brunberg J, Cohan R. Adverse reaction to gadolinium contrast media: a review of 36 cases. American Journal of Roentgenology 1996; 167: 847-9.
24. Nelson K, Gifford L, Lauber-Huber C et al. Clinical safety of gadopentetate dimeglumine. Radiology 1995; 196: 439-42.
25. Jordan R, Mintz R. Fatal reaction to gadopentetate dimeglumine. American Journal of Roentgenology 1995; 164: 743-4.
26. Lasser EC. Contrast media for urography. In: Pollack HM, ed. Clinical urography. Philadelphia, PA: W.B. Saunders &Co., 1990: 23-36.
27. Sheffer A. Anaphylaxis. Journal of Allergy and Clinical Immunology 1985; 75: 227-33.
28. Winbery SL, Lieberman PL. Anaphylaxis. Immunology and Allergy Clinics of North America 1995; 15: 447-76.
29. Genovese A, Stellate C, Marsella C et al. Role of mast cells, basophils and their mediations in adverse reactions to general anesthetics and radiocontrast media International Archives of Allergy and Immunology 1996; 110: 13-22.
30. Bush WH, Swanson DP Radiocontrast. Immunology and Allergy Clinics of North America 1995; 15: 597-612.
31. Grauer K, Cavallaro D. ACLS: certification preparation and a comprehensive review. (Volumes. I and II). St. Louis, MO: Mosby, Lifeline, 1993.
32. Obeid A, Johnson L, Potts J, et al. Fluid therapy in severe systemic reaction to radiopaque dye. Annals of Internal Medicine 1975; 83: 317-21.
33. van Sonnenberg E, Neff CC, Pfister RC. Life-threatening hypotensive reactions to contrast media administration: comparison of pharmacologic and fluid therapy. Radiology 1987; 162: 15-19.
34. Perkin RM, Anas NG. Mechanisms and management of anaphylactic shock not responding to traditional therapy. Annals of Allergy 1985; 54: 201-8.
35. Lasser EC, CC Berry, LB Talner et al. Pretreatment with corticosteroids to alleviate reactions to intravascular contrast media. New England Journal of Medicine 1987; 317: 845-9.
36. Goldberg M. Systemic reactions to intravascular contrast media-a guide for the anesthesiologist. Anesthesiology 1984; 60: 46-56.
37. Yunginger JW. Anaphylaxts. Current Problems in Pediatrics 1992; 22: 130-46.
38. Mayumi H, Kimura S, Asano M. Intravenous cimetidine as an effective treatment for systemic anaphylaxis and acute allergic skin reactions. Annals of Allergy 1987; 50: 447-51.
39. Kelly JS, Prielipp RC. Is cimetidine indicated in the treatment of acute anaphylactic shock? (letter). Anesthesia and Analgesia 1990; 71: 100-106.
40. Runge JW, Martinez JC, Caravati EM, Williamson SG, Hartsell SC. Histamine antagonists in the treatment of acute allergic reactions. Annals of Emergency Medicine 1992; 21: 237-42.
41. Lasser EC, Lang J, Sovak M, Kolb W, Lyon S, Hamlin AE. Steroids: theoretical and experimental basis for utilization in prevention of contrast media reactions. Radiology 1977; 125: 1-9.
42. Greenberger PA, Halwig TM, Patterson R et al. Emergency administration of a radiocontrast media in high-risk patients. Journal of Allergy and Clinical Immunology 1986; 77: 630-35.
43. Netzel MC. Anaphylaxis: clinical presentation, immunologic mechanisms, and treatment. Journal of Emergency Medicine 1986; 4: 227-36.
44. Barach EM, Nowak RM, Tennyson GL, Tomlanovich MC. Epinephrine for treatment of anaphylactic shock. Journal of the American Medical Association 1984; 251:2118-22.
45. Smith NT, Corbascio A. The use and misuse of pressor agents. Anesthesiology 1970; 33:58-101.
46. Hoffman BB, Lefkowitz RJ. Catecholamines and sympathomimetic drugs. In: Gilman AG, Rail TW, Nies AS, Taylor ?, eds. The pharmacological basis of therapeutics. New York: McGraw-Hill Publishers, 1990: 192-8.
47. Ignarro L, Colombo C. Enzyme release from polymorphonuclear leukocyte lysosomes: regulation by autonomic drugs and cyclic nucleotides. Science 1973; 180: 1181-3.
48. Zurier R, Weissmann G, Hoffstein S et al. Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP autonomic agonists, and agents which affect microtubule function. Journal of Clinical Investigation 1974; 53: 297-309.
49. Stoloff R, Adams SL, Orfan N, Harris KE, Greenberger PA, Patterson R. Emergency medical recognition and management of idiopathic anaphylaxis. Journal of Emergency Medicine 1992; 10: 693-8.
50. Ferry DR, Henry RL, Kern MJ. Epinephrine-induced myocardial infarction in a patient with angiographically normal coronary arteries. American Heart Journal 1986; 111: 1193-5.
51. Saff R, Nahhas A, Fink JN. Myocardial infarction induced by coronary vasospasm after self-administration of epinephrine. Annals of Allergy 1993; 70:396-8.
52. Harris JB, Bush WH. How to treat adverse reactions to contrast media. Contemporary Urology 1996; 8: 33-46.
53. Bush WH, McClennan BL. Treatment of adverse contrast media reaction (letter). Radiology 1995; 194: 289.
54. Bush WH, McClennan BL. Epinephrine administration for severe adverse reactions to contrast agents (letter). Radiology 1995; 196: 879.
55. Sadler DJ, Parrish F, Coulthard A. Contrast media reactions (letter). Clinical Radiology 1995; 50: 506.
56. Barach EM. Epinephrine for anaphylactic shock (letter). Journal of the American Medical Association 1985; 253: 510-11.
57. Mueller U, Mosbech H, Blaauw P et al. Emergency treatment of allergic reactions to hymenoptera stings. Clinical and Experimental Allergy 1991; 21: 281-8.
58. Ewan PW. Route of administration of adrenaline for the treatment of anaphylactic reaction to bee or wasp stings (letter). Clinical and Experimental Allergy 1992; 22:753-6.
59. Powers RD, Donowitz LG. Endotracheal administration of emergency medications. Southern Medical Journal 1984; 77: 340-41.
60. Roberts JR, Greenberg ME Baskin SI. Endotracheal epinephrine in cardiorespiratory collapse. Journal of the American College of Emergency Physicians 1979; 8:515.
61. Ingall M, Goldman G, Page LB. Beta-blockade in stinging insect anaphylaxis (letter). Journal of the American Medical Association 1984; 251: 432.
62. Steen PA, Tinkler JH, Pluth JR et al. Efficacy of dopamine, dobutamine and epinephrine during emergence from cardiopulmonary bypass in man. Circulation 1978; 57: 378-85.
63. Lvoff R, Wilcken DEL. Glucagon in heart failure and in cardiogenic shock. Circulation 1972;45:534-9.
64. Entman SS, Moise KJ. Anaphylaxis in pregnancy. Southern Medical Journal 1984; 77: 402.
65. Stanley RJ, Pfister RC. Bradycardia and hypotension following use of intravenous contrast media. Radiology 1976; 121: 5-7.
66. Chamberlain DA, Turner P Sneddon JM. Effects of atropine on heart rate in healthy man. Lancet 1967; 2: 12-15.
67. Fischer HW, Colgan FJ. Causes of contrast media reactions. Radiology 1976; 121: 223.
68. Brown JH. Atropine, scopolamine, and antimuscarinic drugs. In: Gilman AG, Rail TW, Nies AS, Taylor P eds. The pharmacological basis of therapeutics. New York: McGraw-Hill Publishers, 1990: 150-65.
69. Siegle RL, Lieberman R A review of untoward reactions to iodinated contrast material. Journal of Urology 1978; 119: 581-7.
70. Cohan RH, Dunnick NR. Treatment of reactions to radiologic contrast material. American Journal of Roentgenology 1988; 151: 263-7.
71. Cohan RH, Leder RA, Ellis JH. Treatment of adverse reactions to radiographic contrast media in adults. Radiologic Clinics of North America 1996; 34: 1055-60.
72. Lalli AE Contrast media reactions: data analysis and hypothesis. Radiology 1980; 134: 1-12.
73. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? journal of the American Medical Association 1996; 276: 1328-31.
74. Braddom RL, Rocco JF. Autonomic dysreflexia. A survey of current treatment. American journal of Physical Medicine and Rehabilitatwn 1991; 70: 234-41.
75. Delgado-Escueta AV, Wasterlain C, Treiman DM et al. Management of status epilepticus. New England Journal of Medicine 1982; 306: 1337-40.
76. Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. III. Adult advanced cardiac life support. Journal of the American Medical Association 1992; 268: 2199-241.